<table border="1" cellpadding="0" cellspacing="0" width="614" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr>
<td>Table 6: Clarithromycin Susceptibility Test Results andClinical/Bacteriological Outcomes<sup>*</sup>
</td>
</tr>
<tr>
<td>ClarithromycinPretreatment Results</td>
<td>Clarithtromycin Post-treatment Results</td>
</tr>
<tr>
<td> </td>
<td>
<content stylecode="italics">H. pylori</content>negative-eradicated</td>
<td>
<content stylecode="italics">H. pylori </content>positive – noteradicatedPost-treatment susceptibilityresults</td>
</tr>
<tr>
<td>S<sup>†</sup>
</td>
<td>I<sup>†</sup>
</td>
<td>R<sup>†</sup>
</td>
<td>No MIC</td>
</tr>
<tr>
<td>Triple Therapy 14-day (lansoprazole 30 mg twice daily/amoxicillin 1 g twice daily/clarithromycin 500 mg twice daily) (M95-399, M93-131, M95-392)</td>
</tr>
<tr>
<td>Susceptible<sup>†</sup>
</td>
<td>112</td>
<td>105</td>
<td> </td>
<td> </td>
<td> </td>
<td>7</td>
</tr>
<tr>
<td>Intermediate<sup>†</sup>
</td>
<td>3</td>
<td>3</td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td>Resistant<sup>†</sup>
</td>
<td>17</td>
<td>6</td>
<td> </td>
<td> </td>
<td>7</td>
<td>4</td>
</tr>
<tr>
<td>Triple Therapy 10-Day (lansoprazole 30 mg twice daily/amoxicillin 1 g twice daily/clarithromycin 500 mg twice daily) (M95-399)</td>
</tr>
<tr>
<td>Susceptible<sup>†</sup>
</td>
<td>42</td>
<td>40</td>
<td>1</td>
<td> </td>
<td>1</td>
<td> </td>
</tr>
<tr>
<td>Intermediate<sup>†</sup>
</td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td>Resistant<sup>†</sup>
</td>
<td>4</td>
<td>1</td>
<td> </td>
<td> </td>
<td>3</td>
<td> </td>
</tr>
</tbody>
</table>